At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 34 enrolled
Drug / intervention
JZP-110 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apnea
In Brief
A Phase 2 clinical trial evaluating JZP-110 and Placebo for Obstructive Sleep Apnea and Excessive Sleepiness. Completed, enrolled 34 participants across 1 site.
Detailed Summary
This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to obstructive sleep apnea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Excessive Sleepiness
CountriesNetherlands
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJul 2016
Primary CompletionMay 2019
TodayJul 2026
First PostedJun 21, 2016
Enrollment StartJul 5, 2016
Primary CompletionMay 28, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.0 years ago
Interventions
JZP-110drug
Placebodrug